Hitachi High-Tech, an electronics components manufacturer, led a $38m round in Nabsys, a biotechnology company. “Our first-generation HDM instruments have been in customers’ hands for over a year now and have been very well-received,” said Bready. “We are excited to capitalize on the highly scalable nature of our high-speed, single-molecule, electronic detection to increase throughput and expand the application space," Barrett Bready, Nabsys Founder and CEO.